FIT vs gFOBTs: What’s changed? 

Latest from the Blog

NEW COURSE: Oesophageal Cancer – Early Diagnosis

NEW COURSE: Oesophageal Cancer – Early Diagnosis

Thursday 25th February 2021 We are delighted to announce that the new Oesophageal Cancer - Early Diagnosis course is now available on GatewayC. Oesophageal cancer is the 14th most common cancer in the UK, accounting for 3% of all new cancer cases with the highest...

read more
Cancer Keys: Brain Tumours and Headaches

Cancer Keys: Brain Tumours and Headaches

Whilst many people may associate brain tumours with headaches, often affected patients do not present with a headache until a later stage, if at all. Potential pitfall: Only up to 16% of brain tumour patients present to their GP with an isolated headache*; some...

read more

Related Posts

NEW COURSE: Oesophageal Cancer – Early Diagnosis

NEW COURSE: Oesophageal Cancer – Early Diagnosis

Thursday 25th February 2021 We are delighted to announce that the new Oesophageal Cancer - Early Diagnosis course is now available on GatewayC. Oesophageal cancer is the 14th most common cancer in the UK, accounting for 3% of all new cancer cases with the highest...

read more
Assessing peripheral neuropathy

Assessing peripheral neuropathy

Thursday 18th February 2021 It is important for primary care practitioners to explore and assess peripheral neuropathy carefully by evaluating the level of impact on the patient, both physically and emotionally. Many individuals receiving chemotherapy are nervous...

read more

Friday 18th October 2019

The new Faecal Immunochemical Test (FIT) rolled out across England this year has a number of benefits in replacing the use of older guaiac-based faecal occult blood tests (gFOBTs). Is your practice up to date with the new processes associated with FIT and are you aware of the reasons for the change?

Our latest course on Faecal Immunochemical Testing (FIT) is now available, outlining the use of FIT as a screening tool and appropriate use for symptomatic patients. It also includes some of the key benefits of changing to this method from gFOBTs, including:

  • Increased reliability as an indicator of abnormal pathology
  • The need for one patient sample only, compared to the previous three
  • Using antibodies that specifically recognise human haemoglobin
  • Reducing the number of repeat tests, as there are no borderline results (only normal or abnormal)

Find out more:

Find out more: visit the GatewayC Faecal Immunochemical Test course here. 1 CPD credit is available upon completion of this course.

Keep up to date: Twitter | Facebook | LinkedIn

Latest from the Blog

NEW COURSE: Oesophageal Cancer – Early Diagnosis

NEW COURSE: Oesophageal Cancer – Early Diagnosis

Thursday 25th February 2021 We are delighted to announce that the new Oesophageal Cancer - Early Diagnosis course is now available on GatewayC. Oesophageal cancer is the 14th most common cancer in the UK, accounting for 3% of all new cancer cases with the highest...

read more
Cancer Keys: Brain Tumours and Headaches

Cancer Keys: Brain Tumours and Headaches

Whilst many people may associate brain tumours with headaches, often affected patients do not present with a headache until a later stage, if at all. Potential pitfall: Only up to 16% of brain tumour patients present to their GP with an isolated headache*; some...

read more

Related Posts

NEW COURSE: Oesophageal Cancer – Early Diagnosis

NEW COURSE: Oesophageal Cancer – Early Diagnosis

Thursday 25th February 2021 We are delighted to announce that the new Oesophageal Cancer - Early Diagnosis course is now available on GatewayC. Oesophageal cancer is the 14th most common cancer in the UK, accounting for 3% of all new cancer cases with the highest...

read more
Assessing peripheral neuropathy

Assessing peripheral neuropathy

Thursday 18th February 2021 It is important for primary care practitioners to explore and assess peripheral neuropathy carefully by evaluating the level of impact on the patient, both physically and emotionally. Many individuals receiving chemotherapy are nervous...

read more